CoronaVirus UpdatesCoverHeadlines NAFDAC approves production of chloroquine batch for clinical trial By maritimemag March 22, 2020 ShareTweet 0 We did not certify rice sent by Customs to Oyo state -- NAFDAC The National Agency for Food and Drug Administration and Control (NAFDAC), has approved the production of a batch of chloroquine for clinical trials. The Director-General of the agency, Mojisola Adeyeye, made the announcement on Friday. According to Adeyeye, NAFDAC was not approving Chloroquine for the treatment of COVID-19 but for clinical trials to find treatment for the virus. “Right now, we have asked one company to make a batch of Chloroquine for the purpose of the clinical trial.” “NAFDAC is not approving Chloroquine as a product that can be used for Coronavirus because there is no submission to us for registration, but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials. “Therefore, the medicine is being approved just for the clinical trials,” Adeyeye said. Furthermore, she called on experts and researchers that are interested in doing a clinical trial on Chloroquine to approach approved outlets. © 2020, maritimemag. All rights reserved.
CoronaVirus Updates Trade, investment Minister tasks Pharmacists on Covid-19 vaccine production July 26, 2022320 views
CoronaVirus Updates Omicron: Merchant Navy Officers charge employers to provide protective measures for seafarers January 4, 2022534 views
